1-α,25-Dihydroxyvitamin D2 structure
|
Common Name | 1-α,25-Dihydroxyvitamin D2 | ||
---|---|---|---|---|
CAS Number | 60133-18-8 | Molecular Weight | 428.647 | |
Density | 1.1±0.1 g/cm3 | Boiling Point | 577.7±50.0 °C at 760 mmHg | |
Molecular Formula | C28H44O3 | Melting Point | N/A | |
MSDS | Chinese USA | Flash Point | 242.5±24.7 °C | |
Symbol |
GHS02, GHS07 |
Signal Word | Danger |
Use of 1-α,25-Dihydroxyvitamin D2Ercalcitriol (1α,25-Dihydroxy Vitamin D2) is a active metabolite of vitamin D2. IC50 value: Target: Ercalcitriol (1α,25-Dihydroxy Vitamin D2) exhibits equipotent antirachitic activity in rats as calcitriol. Ercalcitriol(1α,25-Dihydroxy Vitamin D2) is a VDR-like Receptors |
Name | 1α,25-dihydroxyvitamin D2 |
---|---|
Synonym | More Synonyms |
Description | Ercalcitriol (1α,25-Dihydroxy Vitamin D2) is a active metabolite of vitamin D2. IC50 value: Target: Ercalcitriol (1α,25-Dihydroxy Vitamin D2) exhibits equipotent antirachitic activity in rats as calcitriol. Ercalcitriol(1α,25-Dihydroxy Vitamin D2) is a VDR-like Receptors |
---|---|
Related Catalog | |
References |
Density | 1.1±0.1 g/cm3 |
---|---|
Boiling Point | 577.7±50.0 °C at 760 mmHg |
Molecular Formula | C28H44O3 |
Molecular Weight | 428.647 |
Flash Point | 242.5±24.7 °C |
Exact Mass | 428.329041 |
PSA | 60.69000 |
LogP | 6.15 |
Vapour Pressure | 0.0±3.6 mmHg at 25°C |
Index of Refraction | 1.554 |
Storage condition | −20°C |
Symbol |
GHS02, GHS07 |
---|---|
Signal Word | Danger |
Hazard Statements | H225-H319 |
Precautionary Statements | P210-P280-P305 + P351 + P338-P337 + P313-P403 + P235 |
Personal Protective Equipment | Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
Hazard Codes | T: Toxic; |
Risk Phrases | R23/24/25;R63 |
Safety Phrases | 36/37-45 |
RIDADR | UN 2811 |
WGK Germany | 3 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Chem. Res. Toxicol. 23 , 171-83, (2010) Drug-induced liver injury is one of the main causes of drug attrition. The ability to predict the liver effects of drug candidates from their chemical structures is critical to help guide experimental... |
|
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
J. Sci. Ind. Res. 65(10) , 808, (2006) Drug-induced liver injury (DILI) is a significant concern in drug development due to the poor concordance between preclinical and clinical findings of liver toxicity. We hypothesized that the DILI typ... |
|
5-lipoxygenase is a direct target of miR-19a-3p and miR-125b-5p.
J. Immunol. 194(4) , 1646-53, (2015) 5-Lipoxygenase (5-LO) is the key enzyme in leukotriene biosynthesis. Leukotrienes are mediators of the innate immune system and inflammatory processes, and they might also be involved in cancer develo... |
(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5S)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol |
1α,25-dihydroxyergocalciferol |
1alpha,25-dihydroxyvitamin D2 |
1α,25-Dihydroxy Vitamin D2 |
(1S,3R,5Z,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraene-1,3,25-triol |
1,3-Cyclohexanediol, 4-methylene-5-[(2E)-2-[(1R,3aS,7aR)-octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-trimethyl-2-hexen-1-yl]-7a-methyl-4H-inden-4-ylidene]ethylidene]-, (1R,3S,5Z)- |
1α,25-Dihydroxycalciferol |
Ercalcitriol |